Nabriva Therapeutics(NBRV)

【仑胜医药】新型抗生素中国III期桥接试验成功！Nabriva股价大涨40%

医药魔方2021-05-27 10:20

5月25日，仑胜医药和Nabriva公司宣布，在中国开展的lefamulin（醋酸截短侧耳素）用于治疗成人社区获得性细菌性肺炎（CABP）的III期桥接试验取得积极结果。受此消息影响Nabriva股价大涨40%。
Lefamulin最初由Nabriva开发，2018年3月仑胜医药获得在大中华区，包括中国大陆、香港、澳门、台湾开...查看全文

fffffffooooo2021-05-27 03:26

$Nabriva Therapeutics(NBRV)$今天做空可以，跌一晚上查看全文

清風竹影2021-05-26 23:51

$Nabriva Therapeutics(NBRV)$ 是时候该拉了……查看全文

鲜克有终72021-02-11 03:44

$Nabriva Therapeutics(NBRV)$ [跪了]12➕查看全文

有为的股价小宝石2020-12-26 02:38

$Nabriva Therapeutics(NBRV)$ @小秘书 这个合股了麻烦改一下查看全文

conkers2020-07-30 12:43

$Nabriva Therapeutics(NBRV)$ 这家伙现在都这价格了查看全文

是毛哥没错2020-07-17 22:30

$Nabriva Therapeutics(NBRV)$ 看分析马上要飞了查看全文

kev88872020-07-17 21:56

$Nabriva Therapeutics(NBRV)$$纳斯达克综合指数(.IXIC)$
劲揪 ✅✅✅查看全文

kev88872020-07-17 01:30

$Nabriva Therapeutics(NBRV)$$纳斯达克综合指数(.IXIC)$
Ⅴ时段查看全文

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-10-31 AccNo: 0001104659-18-065109 Size: 145 KB 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2018-10-31 AccNo: 0001104659-18-065105 Size: 24 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ DEF 14A - Other definitive proxy statements Filed: 2018-10-01 AccNo: 0001047469-18-006504 Size: 648 KB 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K/A [Amend] - Current report Filed: 2018-09-10 AccNo: 0001104659-18-056032 Size: 678 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 9.01: Financial Statements and Exhibits 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ PRE 14A - Other preliminary proxy statements Filed: 2018-09-10 AccNo: 0001047469-18-006094 Size: 610 KB 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-08-10 AccNo: 0000902219-18-000484 Size: 37 KB 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-09 AccNo: 0001104659-18-050835 Size: 3 MB 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2018-08-09 AccNo: 0001104659-18-050795 Size: 194 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-08-07 AccNo: 0001144204-18-042472 Size: 81 KB 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-08-07 AccNo: 0001144204-18-042472 Size: 81 KB 网页链接